B0268 – Rising Inpatient Utilization and Costs of Cannabis Hyperemesis Syndrome Hospitalizations in Massachusetts Following Cannabis Legalization
Monday, October 24, 2022 | 10:00 AM – 12:00 PM ET | Location: Crown Ballroom
Author Insights from Allison Marshall, MD, MPH [&] Sushrut Jangi, MD, Tufts University
What’s new here and important for clinicians?
Following cannabis legalization in Massachusetts, the cost and length of stay for cannabis hyperemesis syndrome have significantly increased.
What do patients need to know?
- Regular and heavy use of cannabis can lead to repeated hospitalizations for nausea and vomiting (called cannabis hyperemesis syndrome), a condition that can be tricky to recognize and diagnose.
- Following cannabis legalization in Massachusetts, patients are staying longer in the hospital and are requiring more resources than before to manage their cannabis hyperemesis syndrome.
Read the Abstract
Allison Marshall, MD, MPH
allison.marshall [at] mountsinai.org
[&] Sushrut Jangi, MD, Tufts University
[&] sjangi [at] tuftsmedicalcenter.org
Media Interview Requests
To arrange an interview with any ACG experts or abstract authors, please contact Becky Abel of ACG via email at mediaonly [at] gi.org or by phone at 301-263-9000.